Compile Data Set for Download or QSAR
Report error Found 26 Enz. Inhib. hit(s) with all data for entry = 2573
TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372167(US10239881, Example A20 | 6-(2-chloro- phenyl)-N- ...)
Affinity DataIC50: 100nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372165(US10239881, Example A18 | N-(4-((4- methylpiperazi...)
Affinity DataIC50: 100nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372164(US10239881, Example A17 | N-(4-(4- methylpiperazin...)
Affinity DataIC50: 100nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372159(US10239881, Example A12 | 6-(2,6- dimethylphenyl)-...)
Affinity DataIC50: 100nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372158(US10239881, Example A11 | N-(3-(4- methylpiperazin...)
Affinity DataIC50: 100nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372156(US10239881, Example A9 | N-(3-((4- methylpiperazin...)
Affinity DataIC50: 100nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372163(US10239881, Example A16 | 2-(4-(3-((6-(2- chloroph...)
Affinity DataIC50: 100nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372162(US10239881, Example A15 | N-(4- (morpholino- methy...)
Affinity DataIC50: 100nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372151(US10239881, Example A4 | N-(3-(4- methylpiperazin-...)
Affinity DataIC50: 100nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372150(US10239881, Example A3 | N-(3- morpholnophenyl)- 6...)
Affinity DataIC50: 100nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372149(US10239881, Example A2 | N-(4-((1- methylpiperidin...)
Affinity DataIC50: 100nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372155(US10239881, Example A8 | N-(4- morpholino- phenyl)...)
Affinity DataIC50: 100nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372154(US10239881, Example A7 | N-(3- (morpholino- methyl...)
Affinity DataIC50: 100nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372153(US10239881, Example A6 | 6-(2,6- dimethylphenyl)- ...)
Affinity DataIC50: 100nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372172(US10239881, Example A25 | 6-(2-methoxy- phenyl)- N...)
Affinity DataIC50: 300nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372160(US10239881, Example A13 | 6-(2-fluorophenyl)- N-(3...)
Affinity DataIC50: 300nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372171(US10239881, Example A24 | N-((tetrahydro- 2H-pyran...)
Affinity DataIC50: 300nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372168((1r,4)-4-((6- (o-tolyl)- 5H-pyrrolo[3,2- d]pyrimid...)
Affinity DataIC50: 300nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372173(US10239881, Example A26 | N-((1- morpholino- cyclo...)
Affinity DataIC50: 500nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372157(US10239881, Example A10 | 6-cyclopentyl- N-(3-(4- ...)
Affinity DataIC50: 500nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372161(US10239881, Example A14 | N-(3- morpholino- phenyl...)
Affinity DataIC50: 500nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372166(US10239881, Example A19 | N-(3- morpholinopropyl)-...)
Affinity DataIC50: 500nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372148(US10239881, Example A1 | N,6-diphenyl-5H- pyrrolo[...)
Affinity DataIC50: 500nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372170(US10239881, Example A23 | N-(tetrahydro-2H- pyran-...)
Affinity DataIC50: 500nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372168((1r,4)-4-((6- (o-tolyl)- 5H-pyrrolo[3,2- d]pyrimid...)
Affinity DataIC50: 500nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
University Health Network

US Patent
LigandPNGBDBM372152(US10239881, Example A5 | 2-(4-(2-methyl- 6-((6- (o...)
Affinity DataIC50: 500nMAssay Description:RIPK2 activity was measured using an indirect ELISA detection system. His RIPK2 (0.6 nM) was incubated in the presence of 6 μM ATP (Sigma cat # ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent